Background The rapid process of research and development and lack of follow-up time post-
vaccination aroused great public concern about the safety profile of COVID-19 vaccine …

Nowadays, the vaccination with COVID-19 vaccines is being promoted worldwide,
professionals and common people are very concerned about the efficacy and safety of …

COVID-19 infection originated in Wuhan, China in December 2019 and crippled human
health globally in no time. The public health emergency required urgent efforts to develop …

Background Various modalities of vaccines against coronavirus disease 2019 (COVID-19),
based on different platforms and immunization procedures, have been successively …

Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …

There is a significant research gap in meta-analysis on the efficacy and safety of coronavirus
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …

This systematic review and meta-analysis was conducted to compare the safety and efficacy
of 2019 novel coronavirus disease (COVID-19) vaccines according to vaccine platform and …

Objective: The presented meta-analysis (MA) aims at identifying the vaccine safety and
immunogenicity in published trials about SARS-CoV-2 vaccines. Methods: All relevant …

Phase 3 randomized-controlled trials have provided promising results of COVID-19 vaccine
efficacy, ranging from 50 to 95% against symptomatic disease as the primary endpoints …

Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …